New Concept 2000 Sprl has been acquired by a private nursing home group
New Concept 2000 Sprl has been successfully sold to a private nursing home group as a consequence of the ongoing consolidation in the Belgian nursing home market. The main driver for this consolidation is stricter regulation and the accompanying need for capital expenditure.
Founded in 1998, New Concept 2000 Sprl owns three nursing homes—La Fontaine, La Colombière and La Roseraie—operating one of them, La Fontaine. In 2008, Wallogistic Sprl was created as a food catering and laundry services provider as well as a central purchasing unit, mainly for hygienic products. Its clients are almost exclusively these three nursing homes, but its scope of activity can be extended to third parties. In 2009, Gesvesenior Asbl was established and is responsible for operating La Colombière and La Roseraie. In total, the company operates more than 160 beds.
The acquirors are private investors who operate a nursing home group with approximately five entities in the Walloon region of Belgium.
The company Wallogistic was not included in the scope of the sale and therefore remains under the sellers’ ownership.
Oaklins’ team in Belgium acted as the exclusive M&A sell-side advisor to New Concept 2000 in this transaction.
Talk to the deal team
Amelie Arrazola de Onate
Oaklins KBC Securities
Related deals
Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.
NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.
Learn moreCreo Medical Group plc has completed a US$15.7 million equity fundraise
Creo Medical Group plc, the provider of pioneering endoscopic healthcare solutions to clinicians and healthcare providers across the world, has completed a US$15.7 million (£12.1 million) equity fundraise.
Learn morePanTera secures US$104.1 million in oversubscribed Series A round to accelerate global actinium-225 production
PanTera, a Belgian radioisotope producer, has completed a US$104.1 million (€93 million) oversubscribed Series A fundraising round led by EQT Life Sciences. Additional equity and debt funding brings the total amount raised to US$150 million (€134 million). In addition to EQT Life Sciences, the Series A round was also joined by Kurma Partners, Eurazeo, Korys, Paladin and PMV.
Learn more